·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
µ¶ÀÚÁ¦º¸
Event
´º½º
Àüü±â»ç
Á¤Ã¥ · ¹ý·ü
Á¦¾à · ¹ÙÀÌ¿À
¾à±¹ · º´¿ø
Ä«µå´º½º
ÆÊTV
À̽´¿µ»ó
DPÃÊ´ë¼®
À̽´Áø´Ü
¾Ë¾Æº¸Àâ
¿ÀÇǴϾð
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
±âÀÚ¼öø
Ưº°±â°í
English
Policy
Opinion
Company
Product
Interview
TVÆʵµ¶ó
ÆÊTube
ÆʼîÇÎ
³ª´Â¾à»ç´Ù
Æʵå¶ó¸¶
ÆʾÆÄ«µ¥¹Ì
ÃʽÉŬ·¡½º
OTC»ó´ã
Á¦Ç°°ÁÂ
Çмú°ÁÂ
°æ¿µ°ÁÂ
Ä¿¹Â´ÏƼ
Æʸ®Äí¸£Æ®
ä¿ëÁ¤º¸
PHARMARCY
ÀÎÀçÁ¤º¸
DPºÎµ¿»ê
¾à±¹»ó´ã¼Ò
¾à»ç´ëÃâ
¾à»ç½Å¿ë´ëÃâ
¼¼¹«»ó´ã
¼¼¹«·³ë¹«
¹ý·ü»ó´ã
¾à±¹°æ¿µ°úâ¾÷
ÀǾàÀÚ·á½Ç
ÀǾàÇàÁ¤
¾à»ç¾à±¹
ÀǷẴ¿ø
Á¦¾àÀ¯Åë
º¸µµÀÚ·á
ÆʽºÅ¸Å¬·´
ÀÎ»ç · ºÎÀ½
¾à±¹ÀåÅÍ
ȸ»ç¼Ò°³
ȸ¿ø°¡ÀÔ
±¤°í¹®ÀÇ
»ç¾÷Á¦ÈÞ
ÀÎÅͳݽŹ®À±¸®°·É
µ¶ÀÚÁ¦º¸
±âÀÚÀ±¸®°·É
ÀÚÀ²¼¾à¼
¿ø°ÝÁö¿ø¿äû
Event & ¼¼¹Ì³ª
Àüü±â»ç
±×·¡ÇÈ
Á¤Ã¥¡¤¹ý·ü
Á¦¾à¡¤¹ÙÀÌ¿À
¾à±¹¡¤º´¿ø
±âȹ¡¤Å½»ç
Àü¹®°¡Ä®·³
µ¥½ºÅ©½Ã¼±
񃯇
񃯇
ÀǾàÇ°
³¹¾Ë½Äº°
µ¥Àϸ®ÆÊ Live Search
´Ý±â
´º½º
>
Àüü ±â»ç
Àüü Çìµå¶óÀÎ ±â»ç
Àüü
|
11-15 (±Ý)
|
11-14 (¸ñ)
|
11-13 (¼ö)
|
11-12 (È)
|
11-11 (¿ù)
|
11-10 (ÀÏ)
|
11-09 (Åä)
Á¦À̺ñÄÉÀÌ·¦, µ¶ÀÚ ½Å±Ô ±â¼ú Àû¿ë ÇѹæÀǾàÇ° Ãâ½Ã
2024-09-03 15:38:32
[µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] ¾à±¹ ä³Î No.1 °Ç°±â´É½ÄÇ° ºê·£µå ¼¿¸Þµå¸¦ ¿î¿µÇÏ´Â Á¦À̺ñÄÉÀÌ·¦(´ëÇ¥ ÀåºÀ±Ù ¹Ú»ç)Àº ȼø Çѹæ Àü¿ë ÀǾàÇ°°øÀå¿¡¼ °³¹ß/»ý»êÇÑ Çѹæ...
À̼®ÁØ ±âÀÚ
Á¤ºÎ "ÀÀ±ÞÁø·á °ø¹é, ÀÇÁ¤°¥µî Å¿ ¾Æ´Ñ °íÁúÀû ¹®Á¦"
2024-09-03 15:27:49
[µ¥Àϸ®ÆÊ=ÀÌÁ¤È¯ ±âÀÚ] ÇöÀç ÀÀ±ÞÀÇ·á°¡ °Þ´Â ¾î·Á¿òÀº ±âÁ¸ ÀÇ·áü°è¿¡¼µµ ÀÖ¾ú´ø ¹®Á¦·Î, À̸¦ °³¼±ÇÏ´Â °Ô ÀÇ·á°³ÇõÀÇ ¸ñÀûÀÔ´Ï´Ù. ¼Óµµ°¨ÀÖ°Ô ÀÇ·á°³ÇõÀ» ÃßÁøÇØ...
ÀÌÁ¤È¯ ±âÀÚ
Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø, Çѱ¹¡¤½ºÀ§½º ³×Æ®¿öÅ©¿Í ¾÷¹«Çù¾à
2024-09-03 14:42:12
[µ¥Àϸ®ÆÊ=õ½ÂÇö ±âÀÚ] Á¦¾à»ê¾÷Àü·«¿¬±¸¿ø(PSI)Àº Çѱ¹-½ºÀ§½º ¹ÙÀÌ¿ÀÁ¦¾à ³×Æ®¿öÅ©(KSBPN)¿Í K-¹ÙÀÌ¿ÀÇコ ±Û·Î¹ú »ýÅ°è Á¶¼º ¹× Çõ½Å¼ºÀåÀ» À§ÇÑ »óÈ£ Çù·Â ¾÷¹«Çù...
õ½ÂÇö ±âÀÚ
ÇѾà»ç¾à±¹ óºÐ À̸£¸é ÀÌÁÖºÎÅÍ¡¦ÇàÁ¤¼Ò¼Û °¡³ª
2024-09-03 12:10:53
[µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] º¸°Çº¹ÁöºÎ°¡ ÇѾà»ç ¾à±¹ 61°÷¿¡ ´ëÇÑ ÇàÁ¤Ã³ºÐÀ» ¿¹°íÇÑ °¡¿îµ¥ À̸£¸é À̹ø ÁÖ, ÁöÀÚü·ÎºÎÅÍ ÅëÁö¼°¡ ¾à±¹¿¡ ¼Û´ÞµÉ Àü¸ÁÀÌ´Ù. Á¤ºÎ°¡ ...
°Çý°æ ±âÀÚ
ƯÇãȸÇÇ ¸·Â÷ ž½Â...Á¦¾à, ¸¯½Ã¾Æ³ª ´Ê±ðÀÌ Æ¯ÇãµµÀü
2024-09-03 12:09:28
[µ¥Àϸ®ÆÊ=±èÁø±¸ ±âÀÚ] Á÷Á¢ÀÛ¿ë °æ±¸¿ë Ç×ÀÀ°íÁ¦(DOAC, Direct Oral Anti-Coagulant) ½ÃÀå ¼±µÎ Á¦Ç°ÀÎ ¸¯½Ã¾Æ³ª(¿¡µ¶»ç¹Ý)¿¡ ´ëÇÑ Á¦³×¸¯»çÀÇ ´Ê±ðÀÌ Æ¯Çã µµÀüÀÌ...
±èÁø±¸ ±âÀÚ
¾àÇаú-ÇѾàÇаú Çг» °¥µî..."¼±¹è´Ô, ÇØ°áÇØÁÖ¼¼¿ä"
2024-09-03 12:05:01
[µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ¾à»ç¿Í ÇѾà»çÀÇ ¾÷¹«¹üÀ§ ħÇØ ¹®Á¦´Â »çȸÀû À̽´»Ó¸¸ ¾Æ´Ï¶ó ´ëÇÐ ±³À°°úÁ¤¿¡¼µµ Çг» °¥µîÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ´Ù. ¾à´ë¿¡¼µµ 4³âÁ¦ ...
Á¤ÈïÁØ ±âÀÚ
PD-1 ¸é¿ªÇ×¾ÏÁ¦ 'Å׺öºê¶ó', Á¾ÇÕº´¿ø ó¹æ±Ç ÁøÀÔ
2024-09-03 12:03:07
[µ¥Àϸ®ÆÊ=¾îÀ±È£ ±âÀÚ] ¸é¿ªÇ×¾ÏÁ¦ Å׺öºê¶ó°¡ Á¾ÇÕº´¿ø ó¹æ±Ç¿¡ ÁøÀÔÇÏ°í ÀÖ´Ù. °ü·Ã¾÷°è¿¡ µû¸£¸é ÃÖ±Ù º£ÀÌÁøÄÚ¸®¾ÆÀÇ PD-1ÀúÇØÁ¦ Å׺öºê¶ó(Ƽ½½·¼¸®ÁÖ¸¿)´Â ...
¾îÀ±È£ ±âÀÚ
Çѹ̾àÇ°, »óÇØÀǾà±×·ì°ú ÀϹݾà 7Á¾ À¯Åë °è¾à
2024-09-03 12:01:54
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] Çѹ̾àÇ°ÀÌ Áß±¹ ÃÖ´ë Á¦¾à±â¾÷ Áß ÇϳªÀÎ »óÇØÀǾà(Shanghai Pharma)±×·ì ÀÚȸ»ç Shanghai Pharma Health Science¸¦ ÅëÇØ ÀÚü °³¹ßÇÑ ÀϹÝÀÇ...
¼ÕÇü¹Î ±âÀÚ
"±¹»ê½Å¾à '¿£ºí·Î', ½Å¼Ó Çã°¡ ¹è°æÀº Á¤Ã¥ Áö¿ø"
2024-09-03 12:00:39
[µ¥Àϸ®ÆÊ=ÀÌÇý°æ ±âÀÚ] ½ÄÇ°ÀǾàÇ°¾ÈÀüó ½Å¼Ó½É»çÀÇ ´ëÇ¥Àû ¼º°ø »ç·ÊÀÎ ´ë¿õÁ¦¾àÀÇ ¿£ºí·ÎÁ¤0.3mg(À̳ªº¸±Û¸®Ç÷ÎÁø)ÀÌ ÀÓ»óºÎÅÍ Çã°¡±îÁö ´Ü 5³â¸¸¿¡ ²÷Àº ÀÌÀ¯´Â ...
ÀÌÇý°æ ±âÀÚ
°æº¸¡¤Á¦ÀÏ¡¤ÇÑ¹Ì µî ±¹³» Á¦¾à¾÷°è ÇϹݱâ ÀÎÀç ¸ðÁý
2024-09-03 12:00:11
[µ¥Àϸ®ÆÊ=¼ÕÇü¹Î ±âÀÚ] °æº¸Á¦¾à, ´ëÈÁ¦¾à, Á¦ÀϾàÇ°, Çѹ̾àÇ°, Çѵ¶ µî ±¹³» Á¦¾à¹ÙÀÌ¿À¾÷°è°¡ ÇϹݱâ ÀÎÀç ¸ðÁýÀ» ÁøÇàÇÏ°í ÀÖ´Ù. »ï¿ø¾àÇ°°ú Á¦ÀÏÇコ»çÀ̾𽺴 ...
¼ÕÇü¹Î ±âÀÚ
<
241
242
243
244
245
246
247
248
249
250
>
ä¿ë
¼Óº¸
ÆʼîÇθô
ÀǾàÇ°¸ô
Çコ¿ëÇ°¸ô
±âŸ»óÇ°¸ô
¸ÞµðÄ«ÄÚ¸®¾Æ
¿¥¿¡ÇÁ¾¾
À¯´Ï¸Þµå
¶ó¿ÂÆĸ¶
Çdzª¿ÂÁ¤
À¯´Ï¸ÞµåÁ¦¾à
À¯´Ï¼¾Å¸¾×
¸ÞµðÄ«ÄÚ¸®¾Æ
ÃÊÀÓ°è¾ËƼÁö
À¯´Ï¸ÞµåÁ¦¾à
¸ÞµðÆʸô
¸ÞµðÄ®Çö´ë
¸¶´õ½ºÁ¦¾à
¸¶´õ½ºÁ¦¾à
ÄÜƼ600
¿¹½ºÅ²
¿ÀºÐ¾ÖÆ÷¸£Å×
´õÆÊ
½ãµðµå·Ó½º
ÀͼöÁ¦¾à
Àͼö°øÁø´Ü
ÈÞº£À̽º
KnH¸ÞµðÅØ
°æ¹æ½Å¾à
¸Þµð¶óÀÌÇÁ
ÂøÇѳª¹«ÀÎÅ׸®¾î
³»¼Õ¾ÈÀÇ ¾à±¹
´ÚÅ;ØÆÊ
ÀǾàÇ° Àü¹®¹è¼Û ÆĹÌ
¾à±¹ÀÎÅ׸®¾î
¾à»ç´Ô ÀÔ¼Ò¹®
¼±ÅÃÀÇ ÆøÀ̳оîÁø ¾à±¹Ã¼ÀÎ
°æ¹æ½Å¾à
°æ¿Á°í
¾Ë¸² ¡¤ °øÇ¥
±³À° ¡¤ °ÁÂ
¾à±¹»ó´ã¼Ò
Á¢¼ö ¡¤ ¹®ÀÇ
¾Ë¸²
[Â÷ÀÇ°úÇдëÇÐ]ÀÓ»ó¾àÇдëÇпø Àü±â¸ðÁý GO¢º
¾Ë¸²
Æ÷ÅÙ²ËÂ÷ Æ÷ÅÙ½ºÆ½! ¼º£ÀÌ Âü¿©ÇÏ·¯ GO>
¾Ë¸²
ÇÁ·»Áî ¾ÆÀ̵å·Ó ¾ÆÀ̽º ·±Äª EVENT GO¢º
°øÇ¥
¿µÁø¾àÇ°(ÁÖ) ÀǾàÇ° ȸ¼ö¿¡ °üÇÑ °øÇ¥
¾Ë¸²
Á¦ 15ȸ ´ÚÅ;ØÆÊ °³±¹ ¼¼¹Ì³ª 11¿ù 17ÀÏ(ÀÏ) GO¢º
¾Ë¸²
»ç°èÀý ¹«Á» »ó´ã ÇØ°áÃ¥! ¶ó¹Ì½Ç ¿ø½º EVENT GO¢º
D-46
[ÆÊŬ·¡½º]Àü°Á ¹«Á¦ÇÑ ½Ãû! (Ç×½ÃÁ¢¼ö) ( ~12.31 )
D-46
[ÆʽºÅ͵ð]ij³ª´Ù ¾à»ç ÀÚ°ÝÁõ[Ç×½ÃÁ¢¼ö] ( ~12.31 )
D-46
Á¦ 15ȸ ´ÚÅ;ØÆÊ °³±¹ ¼¼¹Ì³ª 11¿ù 17ÀÏ(ÀÏ) GO¢º ( ~12.31 )
D-19
Çѱ¹Á¦¾à¹ÙÀÌ¿ÀÇùȸ [±Û·Î¹ú BD Àü¹®±³À°] ( ~12.04 )
D-21
[Á¦¾à»ý¸í°øÇоÆÄ«µ¥¹Ì] ¿Â¶óÀÎ ±³À°½Åû GO ( ~12.06 )
¼¼¹«»ó´ã
Æó¾÷¿¹Á¤Àε¥ ¹®Àǵ帳´Ï´Ù
¹ý·ü»ó´ã
´ëüÁ¶Á¦½Ã »çÀüµ¿ÀÇ¿©ºÎ
¾à»ç´ëÃâ
³ªÀ̴»ó°ü¿²³ª¿ä
¾à±¹ÈÀåÇ°
Æ°»ìÅ©¸² ¹®ÀÇ
¾à±¹°æ¿µ°ú â¾÷
¿äÁò »õ·Î °³¼³µÇ´Â ¾à±¹Àº Áø¿ÀåÀÌ È®½ÇÈ÷ ÀÌÀü
¼¼¹«¡¤³ë¹«
Æó¾÷¿¹Á¤°ü·Ã ¹®Àǵ帳´Ï´Ù
±³À° °Á ¹× ¾Ë¸² ±¤°í ¾È³» ÆäÀÌÁö
¿¬¼ö, ±³À°, ¼¼¹Ì³ª, Çмú°Á ¹× ±â¾÷±³À°, ¸ðÁý
°øÇ¥, Åä·Ðȸ, ÀǾàÇ° º¯°æ ¾È³» ¹× °¢Á¾ Çà»ç
¾Ë¸² ±¤°í¸¦ Çص帳´Ï´Ù.
(Á¢¼ö ¹®ÀÇ ¹Ù·Î°¡±â)
¿À´ÃÀÇ
ÇÖ´º½º
1
Á¦ÁÖ ´ëÇü¾à±¹ 65¾ï´ë ȯ¼ö ±â·Î¡¦À¯Åë¾÷°è ÃË°¢
2
º¹ÁöºÎ, ´ëüÁ¶Á¦ °£¼ÒÈ ¼ö¿ë ÀÔÀå ¹øº¹..."½ÅÁß°ËÅä"
3
¹°¼ö´É¿¡ ¾à´ë Çհݼ±¡è...¼¿ï´ë 279Á¡, Áß¾Ó´ë 272Á¡
4
2õ¾ï »ç¸£Æ÷¡¤·¹º¸µå·Î ¾à°¡ÀÎÇÏ...Á¦¾à»ç ¼Õ½Ç Çö½ÇÈ
5
ºÎµµ À§±â ¹®Àü¾à±¹ ä±Ç¾÷ü Ä«µå»ç 7°÷¡¤À¯Åë 11°÷
6
ÃÖ±¤ÈÆ 37.6%, ±Ç¿µÈñ 28.6%, ¹Ú¿µ´Þ 21.6%
7
³»³â µ¿µî¼º ÀçÆò°¡ ĸ½¶¡¤¾×Á¦ µî 210Ç°¸ñ È®Á¤
8
'Â÷ÀͽÇÇö°ú ÁֽĻóÀå'...µ¿È¾àÇ°, ½ò½òÇÑ ÅõÀÚÀü·« °á½Ç
9
»óÀåÁ¦¾à 5°÷ Áß 3°÷ ¼öÀͼº °³¼±¡¦ÀÇ·á°ø¹é ¾ÇÀç ¼±¹æ
10
'¿¬ 2ȸ Åõ¿©' °íÁöÇ÷Áõ ½Å¾à ·ººñ¿À, ½ÃÀå °ø·« äºñ